Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Description: About Organization Rakuten Symphonys CPaaS (Communication Platform as a Service) business unit is a rapidly growing, dynamic team providing cloud messaging platforms to enterprise customers. As we scale our direct sales capabilities, we are